Search
01/01/2026
Acute Postoperative Pain After Caesarean Section, Intensity and Management: A Cohort Multicentre Study
Ramírez, CE, Obiols, PC, Martínez-Rodríguez, D, Raynard, M, Draper, BV, Masgoret, P, Cosmen, CR, Giménez, LS, García, MM, Mestres, G, Melo, M, Galindo, AN, Gaig, NM, Sánchez-Migallón, V, Royo, DV, Comino, NLP, Perez, IB, Farré, CS, Salillas, LT, Gelabert, AA, Homs, M, Ribas, P, Teixell, C, Moral, AMP, Tena, B, Castiñeira, AF, Gay, MA, Pelai, BF, Bartoló, CG, Iniesta, CM, Font, AP, Esteller, PG, Clave, JL, Pera, SG, Batalla, A, Giménez, VR, Amatria, GR. Acute Postoperative Pain After Caesarean Section, Intensity and Management: A Cohort Multicentre Study. EUROPEAN JOURNAL OF PAIN. 2026; 30(1)DOI:10.1002/ejp.70183. PMID:41317004. IF:3.400(Q1/1D).
01/01/2026
Surveillance of Non-Malignant Asbestos-Related Diseases in an Exposed Population: A Scoping Review
De La Pava-Cortés, C, Torres, EP, Driscoll, T, Jones, C, Coles, J, McArdle, S, Brislane, K, Peters, M, Villamizar, G, Algranti, E, Frank, A. Surveillance of Non-Malignant Asbestos-Related Diseases in an Exposed Population: A Scoping Review. Annals of Global Health. 2026; 92(1)DOI:10.5334/aogh.4983. PMID:41728043. IF:3.200(Q1/3D).
01/01/2026
Musculoskeletal disorders in musicians: an overview of systematic reviews
Cerda-Díaz, L, Antúnez-Riveros, M, Bracchiglione, J, Opazo-Campusano, R, Núñez-Cortés, R. Musculoskeletal disorders in musicians: an overview of systematic reviews. OCCUPATIONAL MEDICINE-OXFORD. 2026; 76(1)DOI:10.1093/occmed/kqaf126. PMID:41691705. IF:1.700(Q3/7D).
01/01/2026
Intermittent fasting for adults with overweight or obesity (Review)
Garegnani, LI, Oltra, G, Ivaldi, D, Burgos, MA, Andrenacci, PJ, Rico, S, Boyd, M, Radler, D, Liquitay, CME, Madrid, E. Intermittent fasting for adults with overweight or obesity (Review). COCHRANE DATABASE OF SYSTEMATIC REVIEWS. 2026; (2)DOI:10.1002/14651858.CD015610.pub2. PMID:41692034. IF:9.400(Q1/1D).
01/01/2026
Current use and perspectives of PET imaging in Alzheimer's disease: A Spanish national survey
Cabrera-Martín, MN, Aguiar-Fernández, P, Camacho-Martí, V, Guillén-Valderrama, EF, Jiménez-Bonilla, JF, Lojo-Ramírez, JA, López-Mora, DA, Matías-Guiu, JA, Paredes-Rodríguez, P, Perissinotti, A, Arbizu, J. Current use and perspectives of PET imaging in Alzheimer's disease: A Spanish national survey. Journal Of Alzheimers Disease Reports. 2026; 10DOI:10.1177/25424823261437129. PMID:. IF:(Q/D).
01/01/2026
Accuracy of large language models in interpreting urological clinical guidelines: a comparative study with expert evaluation
Borque-Fernando, A, Navarro, D, Doblare, M, Esteban, LM, Perez-Fentes, D, Alvarez-Maestro, M, Medina-López, RA, Faba, OR, Rubio-Briones, J, Fernández-Pello, S, Fernández-Gómez, JM, Aparicio, TF, Ramos, FG, Izquierdo, L, Fernández, JLAO. Accuracy of large language models in interpreting urological clinical guidelines: a comparative study with expert evaluation. Therapeutic Advances in Urology. 2026; 18DOI:10.1177/17562872261436905. PMID:41918915. IF:3.500(Q1/2D).
01/01/2026
Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU
Vivas, D, Ferrandis, R, Anguita-Sánchez, M, Anguita-Gámez, M, Arcelus, JI, Echeverri, M, Egocheaga, I, Esteve-Pastor, MA, Ferreiro, JL, Llau, JV, Roldán, V, Ruiz-Nodar, JM, González-Casal, D, Torres-Fonseca, M, López-Menéndez, J, Ciria, M, Leyva, F, de Santiago, ER, Vidán, MT, Pamplona, L, Mingot-Castellano, ME, Mateo-Arranz, J, Polo, J, Castellanos, A, Llanos, C, Madridano, O, Jiménez, S, Freijo, MD, Puchades, MJ, Lafuente, J, Jiménez, D, Santos-Bueso, E, Ferrandis, E, Figuero, E, González-Nieto, CJ, Castel, A, Hermida, JF, Marín, F, Rodríguez-Padial, L, Fernández-Lozano, I, Hidalgo, F, Cassinello, C, Muñoz, E, Palomo-López, N. Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(1)DOI:10.1016/j.rec.2025.09.003. PMID:40983168. IF:4.900(Q1/2D).
01/01/2026
Evaluation of Fibrinolysis Testing Methods in Haemostasis and Thrombosis Laboratories: Results of a National Survey by the Spanish Society on Thrombosis and Haemostasis (SETH) Laboratory Working Group
Revilla, N, Gutierrez, AB, Alén, AR, Martínez, AM, Franco, CA, Díaz, CG, Alonso, CM, Aisa, CS, Jiménez, DF, Espino, EM, Arteta, EG, Jaime, FJL, Ortega, IS, Martíinez, IM, Upegui, I, Pego, JM, Tovar, JC, Vila, JGA, Bastida, JM, Juaristi, KA, Lopez, MR, Rodríguez, MF, Paloma, MJ, Muñoz, MJS, Jubilar, MM, Massaro, MT, Docampo, MF, Miguélez, MSO, Vilalta, N, Sebastian, OG, Culebras, RA, Giner, VC, Villas, JMC, Butta, N. Evaluation of Fibrinolysis Testing Methods in Haemostasis and Thrombosis Laboratories: Results of a National Survey by the Spanish Society on Thrombosis and Haemostasis (SETH) Laboratory Working Group. HAEMOPHILIA. 2026; 32DOI:. PMID:. IF:3.000(Q2/4D).
01/01/2026
Enhancing Physical Activity in Patients Treated With Emicizumab in Hemophilia A: Results From the HEMO-ACT Cross-Sectional Study
De la Corte, H, Expósito, MC, De Paz, MR, Ureña, LE, Jaime, FJL, Canaro, M, Coll, J, Candel, FG, Hidalgo, O, Boix, SB, Lucas, J, Vázquez, RN, Mesa, A, Sanchez, VB, Román, TA. Enhancing Physical Activity in Patients Treated With Emicizumab in Hemophilia A: Results From the HEMO-ACT Cross-Sectional Study. HAEMOPHILIA. 2026; 32DOI:. PMID:. IF:3.000(Q2/4D).
01/01/2026
Recurrent pituitary apoplexy: experience from a national registry and review of the literature
Biagetti, B, Asanza, EC, Iglesias, P, Camara, R, Asla, Q, Vicente, A, Martinez-Saez, E, Sarria-Estrada, S, Puig-Domingo, M, Araujo-Castro, M. Recurrent pituitary apoplexy: experience from a national registry and review of the literature. Therapeutic Advances in Endocrinology and Metabolism. 2026; 17DOI:10.1177/20420188261434641. PMID:41919183. IF:4.600(Q1/3D).
01/01/2026
Unravelling sex-specific differences in autosomal dominant polycystic kidney disease: a multiorgan perspective
Furlano, M, Tinoco, A, Toso, D, Polo, A, Martínez, O, Llurba, E, Espí, BC, Maestre, F, Marco, H, Torra, R. Unravelling sex-specific differences in autosomal dominant polycystic kidney disease: a multiorgan perspective. Clinical Kidney Journal. 2026; 19(1)DOI:10.1093/ckj/sfaf359. PMID:41788616. IF:4.600(Q1/2D).
01/01/2026
Haemodynamic monitoring and management of the hypotensive out-of-hospital cardiac arrest patient in the adult intensive care unit: a clinical consensus statement of the Association for Acute CardioVascular Care of the ESC
Grand, J, Sionis, A, Hassager, C, Perez, PJ, Poess, J, Schaubroeck, H, Desch, S, Krychtiuk, KA, Belohlavek, J, Mebazaa, A, Huber, K, van Diepen, S, Vandenbriele, C, Morrow, D, Tavazzi, G. Haemodynamic monitoring and management of the hypotensive out-of-hospital cardiac arrest patient in the adult intensive care unit: a clinical consensus statement of the Association for Acute CardioVascular Care of the ESC. European Heart Journal-Acute Cardiovascular Care. 2026; 15(1)DOI:10.1093/ehjacc/zuaf125. PMID:41014602. IF:4.600(Q1/2D).
01/01/2026
Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study (vol 15, e95267, 2026)
Giné-Balcells, R, Vlacho, B, Vidal-Pérez, OC, Lecub, A, Franch-Nadal, J, Mauricio, D, Molló-Iniesta, A, Hernández, M. Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study (vol 15, e95267, 2026). Jmir Research Protocols. 2026; 15DOI:10.2196/95267. PMID:. IF:(Q/D).
01/01/2026
Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study
Giné-Balcells, R, Vlacho, B, Vidal-Pérez, OC, Lecube, A, Franch-Nadal, J, Mauricio, D, Molló-Iniesta, A, Hernández, M. Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study. Jmir Research Protocols. 2026; 15DOI:10.2196/85375. PMID:41734338. IF:(Q/D).
01/01/2026
Preoperative localization of metastatic axillary lymph nodes using radioactive iodine seed before neoadjuvant chemotherapy. A one-step marking method for targeted axillary dissection
Macedo, M, Agustí, E, Ganau, S, Ubeda, B, Sitges, C, Ribera-Perianes, J, Oses, G, Pascual, T, Mension, E, Vidal-Sicart, S, Bargalló, X. Preoperative localization of metastatic axillary lymph nodes using radioactive iodine seed before neoadjuvant chemotherapy. A one-step marking method for targeted axillary dissection. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2026; 53(2)DOI:10.1007/s00259-025-07481-y. PMID:40742538. IF:7.600(Q1/1D).
01/01/2026
Next-generation biomarkers for cancer-associated thrombosis prediction: the role of non-genomic-omics
Soria, JM, Souto, JC, Muñoz, A. Next-generation biomarkers for cancer-associated thrombosis prediction: the role of non-genomic-omics. Bleeding, Thrombosis And Vascular Biology. 2026; 5DOI:10.4081/btvb.2026.447. PMID:. IF:(Q/D).
01/01/2026
Incretin-based Agents and Metabolic Dysfunction-associated Steatotic Liver Disease
Muzurovic, E, Haluzik, M, Horváth, L, Vlacho, B, Mauricio, D. Incretin-based Agents and Metabolic Dysfunction-associated Steatotic Liver Disease. CURRENT PHARMACEUTICAL DESIGN. 2026; 32(20)DOI:10.2174/0113816128378484250619080753. PMID:40641020. IF:2.800(Q2/5D).
01/01/2026
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29-30 October 2021: Remote Monitoring: New Solutions for New Avenues in Neuromuscular Disorders
Schirinzi, E, Bochicchio, MA, Lochmüller, H, Vissing, J, Jordie-Diaz-Manerae, Evangelista, T, Plançon, JP, Fanucci, L, Marini, M, Tonacci, A, Mancuso, M, Segovia-Kueny, S, Toscano, A, Angelini, C, Schoser, B, Sacconi, S, Siciliano, G. E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29-30 October 2021: Remote Monitoring: New Solutions for New Avenues in Neuromuscular Disorders. Journal Of Neuromuscular Diseases. 2026; 13(1)DOI:10.3233/JND-230091. PMID:38728200. IF:3.400(Q2/3D).
01/01/2026
Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's disease
Franch-Marti, C, Puig-Davi, A, Rodriguez-Antiguedad, J, Perez-Perez, J, Olmedo-Saura, G, Ruiz-Barrio, I, Bojtos, L, Perez-Carasol, L, Tort-Merino, A, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's disease. Brain Communications. 2026; 8(3)DOI:10.1093/braincomms/fcag210. PMID:42339152. IF:(Q/D).
01/01/2026
Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study
Ellebaek, E, Weichenthal, M, Gavrilova, I, Asher, N, Terheyden, P, Utikal, J, Suljeviic, AJ, Pföhler, C, Stojkovski, I, Herbst, RA, Ugurel, S, Ruhlmann, C, Berrocal, A, Majem, M, Dujovic, B, Sabaric, V, Duvancic, T, Soria, A, Donia, M, Schmidt, H, Friis, RB, Gerasimov, A, Shalamanova-Deleva, G, Kontilev, A, Lev-Ari, S, Shapira, R, Piccin, L, Minisini, A, Özdemir, BC, Teterycz, P, Mariuk-Jarema, A, Ziogas, D, Anastasopoulou, A, Stefanou, D, Gutiérrez, L, Gebhardt, C, Dummer, R, Hauschild, A, Mohr, P, von Wasielewski, I, Meier, F, Haanen, J, Svane, IM, Ascierto, PA, Mangana, J, Rutkowski, P, Gogas, H, Bastholt, L, Schadendorf, D. Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study. Ejc Skin Cancer. 2026; 4DOI:10.1016/j.ejcskn.2025.100773. PMID:. IF:(Q/D).